A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beijing Tongren Hospital
Alliance for Clinical Trials in Oncology
Children's Oncology Group
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
Dana-Farber Cancer Institute
Children's Oncology Group
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Regeneron Pharmaceuticals
Washington University School of Medicine
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Barbara Ann Karmanos Cancer Institute
University of Liverpool
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Universitätsklinikum Hamburg-Eppendorf
University of Colorado, Denver
Children's Oncology Group
Columbia University
Gilead Sciences
Ipsen
University of Nebraska
Children's Oncology Group
Huashan Hospital
OHSU Knight Cancer Institute
Trans Tasman Radiation Oncology Group
M.D. Anderson Cancer Center
University of California, Davis
Mesoblast, Ltd.
Gruppo Italiano Malattie EMatologiche dell'Adulto
H. Lee Moffitt Cancer Center and Research Institute
UNICANCER
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Masonic Cancer Center, University of Minnesota